▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #521 by analyst upside · 2026-06-27
CDXS
Codexis, Inc.
Healthcare · Market Cap $217M · P/E 0x
ANALYST PRICE TARGET
+175.5%
implied upside to consensus target
Current Price $2.39
Consensus Target $6.58
Bull Target $11.0
Bear Target $2.0
Analysts Covering 6
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
3
Hold
2
Sell
0
52-Week Low $0.96
52-Week High $3.87
YTD Return +48.4%
FUNDAMENTALS
Market Cap $217M
P/E Ratio (TTM) N/A
Forward P/E -6.5x
EPS (TTM) $-0.35
PEG Ratio 13.53
Dividend Yield N/A
Revenue (TTM) $78M
Profit Margin -41.0%
52-WEEK RANGE
52-Week Low $0.96
52-Week High $3.87
Current Price $2.39
Bear Target $2.0
Bull Target $11.0
● Now $2.39 ● Target $6.58
TRADING DATA
Avg Volume 1.1M
YTD Return +48.4%
Analyst Count 6
Consensus Buy
Upside to Target +175.5%
Last Updated 2026-06-27

ANALYST SUMMARY

Codexis, Inc. (CDXS) is currently trading at $2.39 with a Wall Street consensus price target of $6.58, implying potential upside of 175.5% over the next 12 months. 6 analysts currently cover CDXS, with a consensus rating of Buy - 67% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $11.0, while the most cautious has a target of $2.0.

CDXS operates in the Healthcare sector with a market capitalisation of $217M. The stock is up 48.4% year-to-date and is currently trading near the lower end of its 52-week range of $0.96 – $3.87.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

CGEN +120.1%
Compugen Ltd.
$198M · P/E 5.4x · Buy
OPRX +142.2%
OptimizeRx Corporation
$96M · P/E 13.5x · Buy
CCLD +184.9%
CareCloud, Inc.
$91M · P/E 16.5x · Buy
KMDA +79.1%
Kamada Ltd.
$419M · P/E 20.7x · Buy
XTNT +193.6%
Xtant Medical Holdings, Inc.
$59M · P/E 42.0x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for CDXS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Cantor Fitzgerald reit
Overweight → Overweight 2024-11-22 40% win rate (10 calls)
Cantor Fitzgerald reit
Overweight → Overweight 2024-11-15 40% win rate (10 calls)
Benchmark reit
Hold 2024-11-04 Building track record
Cantor Fitzgerald reit
Overweight → Overweight 2024-09-20 40% win rate (10 calls)
Cantor Fitzgerald reit
Overweight → Overweight 2024-08-29 40% win rate (10 calls)
Benchmark ↓ Downgrade
Buy → Hold 2024-08-19 Building track record
Cantor Fitzgerald reit
Overweight → Overweight 2024-08-09 40% win rate (10 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
29
out of 100
Coverage depth
15/30
Consensus clarity
0/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →